Next to Bevacizumab, the LMWH Tinzaparin also specifically blocked VWF secretion after incubation of LECs and HUVECs with supernatants of melanoma cells, whereas Fo ndaparinux showed no effect (Figure 1C). Here, VWF is linked to melanoma.